The Genmab share is listed on the Danish C25 index on the Copenhagen Stock Exchange. You can follow the stock’s development below.
Genmab is a double-listed company and their shares are traded on both the Copenhagen Stock Exchange in Denmark and on the NASDAQ Global Select Market in the USA.
Genmab is a biotech company that develops cancer medicine in Copenhagen. The company is best known for their antibody platforms, DuoBody, HexaBody and not least their upcoming multiple myeloma drug Darzalex, which they manufacture in collaboration with American Johnson & Johnson. They also have a number of other leading products in other cancer indications and autoimmune diseases.
